$Alzamend Neuro (ALZN.US)$Alzamend Neuro Tells Benzinga 'Data Confirm the Positive Topline Results Announced in June 2023 Identifying a Maximum Tolerated Dose as Assessed by an Independent Safety Review Committee'!
Alzamend Neuro Tells Benzinga 'Identified Dose Is Unlikely to Require Lithium Therapeutic Drug Monitoring'
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Teo knows : Good news but nothing new
Trytosaveabit OP Teo knows : Just confirmation with a bit more data! Which gets them closer to FDA